| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 352,070 | 312,690 | 561,133 | 714,780 | | Cost of Revenue | 207,100 | 181,915 | 371,595 | 471,307 | | | Gross Profit | 144,970 | 130,775 | 189,538 | 243,473 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 116,444 | 121,708 | 109,255 | 123,908 | | Non Recurring |
-
| 4,118 | 2,323 | 4,019 | | Others | 20,527 | 20,324 | 20,635 | 20,219 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 6,337 | (15,375) | 57,325 | 95,327 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (18,663) | (13,012) | (190) | (343) | | Earnings Before Interest And Taxes | (10,664) | (28,387) | 57,135 | 94,984 | | Interest Expense | 22,695 | 20,429 | 22,027 | 23,393 | | Income Before Tax | (33,359) | (48,816) | 35,108 | 71,591 | | Income Tax Expense | (422) | (421) | 1,847 | 1,167 | | Minority Interest | 272 | 296 | (397) | (772) | | | | Net Income From Continuing Ops | (49,973) | (48,099) | 32,864 | 69,652 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (32,665) | (35,057) | 32,864 | 69,652 | | Preferred Stock And Other Adjustments |
-
| 350 | (328) | (548) | | | Net Income Applicable To Common Shares | ($32,665) | ($34,707) | $32,536 | $69,104 |
|
0.02% Nasdaq 0.00%
Income Statement
